Cytokeratin 19 Antikörper
(2 Referenzen)Kurzübersicht für Cytokeratin 19 Antikörper (ABIN94290)
Target
Alle Cytokeratin 19 (KRT19) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-Cytokeratin 19 Purified
-
Spezifität
- The mouse monoclonal antibody A53-B/A2 recognizes the rod domain of cytokeratin 19 (40 kDa), an intracellular antigen constituting intermmediate cytoskeleton filaments. Cytokeratin 19 is not expressed in hepatocytes, it is often co-expressed with cytokeratin 7.
-
Kreuzreaktivität (Details)
- Human
-
Aufreinigung
- Purified by protein-A affinity chromatography.
-
Reinheit
- > 95 % (by SDS-PAGE)
-
Immunogen
- MCF-7 human breast adenocarcinoma cell line
-
Isotyp
- IgG2a
-
-
anti-Keratin 19 (KRT19) antibody
KRT19 Reaktivität: Human WB, IHC (p), ICC, IP, ICFC Wirt: Maus Monoclonal BA-17 unconjugated
anti-Keratin 19 (KRT19) (AA 245-391) antibodyKRT19 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 245-391) antibodyKRT19 Reaktivität: Human WB, IHC, ICC, IP Wirt: Maus Monoclonal D1 unconjugated
anti-Keratin 19 (KRT19) (AA 1-403) antibodyKRT19 Reaktivität: Maus WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 127-322) antibodyKRT19 Reaktivität: Human WB, IHC, ICC, IP Wirt: Maus Monoclonal C1 unconjugated
anti-Keratin 19 (KRT19) (AA 241-400) antibodyKRT19 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 274-400) antibodyKRT19 Reaktivität: Human WB, IHC, ELISA Wirt: Maus Monoclonal 8H1A8 unconjugated
anti-Keratin 19 (KRT19) (AA 80-400) antibodyKRT19 Reaktivität: Human, Ratte WB, IHC, FACS, ELISA Wirt: Maus Monoclonal 2A1G9 unconjugated
anti-Keratin 19 (KRT19) antibodyKRT19 Reaktivität: Human, Maus, Ratte IHC, IF, FACS, StM Wirt: Maus Monoclonal KRT19-800 unconjugated
anti-Keratin 19 (KRT19) antibodyKRT19 Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal KRT19-799 unconjugated
-
-
Applikationshinweise
-
Flow cytometry: Recommended dilution: 1-5 μg/mL. Intracellular staining.
Immunohistochemistry: Recommended dilution: 5-10 μg/mL.
Western blotting: Recommended dilution: 1-2 μg/mL, positive control: MCF-7, BA-17, HT-29 cells. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C. Do not freeze.
-
-
-
: "Patterns of cytokeratin and vimentin expression in the human eye." in: Histochemistry, Vol. 89, Issue 4, pp. 369-77, (1988) (PubMed).
: "Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion." in: European journal of cancer & clinical oncology, Vol. 21, Issue 6, pp. 733-40, (1985) (PubMed).
-
: "Patterns of cytokeratin and vimentin expression in the human eye." in: Histochemistry, Vol. 89, Issue 4, pp. 369-77, (1988) (PubMed).
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Andere Bezeichnung
- Cytokeratin 19
-
Hintergrund
- Keratin 19,Cytokeratins are a subfamily of intermediate filaments and characterized by remarkable biochemical diversity. They are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individual cytokeratin polypeptides are designated 1 to 20 and divided into the type I (acidic cytokeratins 9-20) and type II (basic to neutral cytokeratins 1-8) families.,K19, CK19, CYK19, KRT19, K1CS
-
Gen-ID
- 3880
-
UniProt
- P08727
Target
-
